Search research articles
Contact Us
Filters
Showing results (301-310 of 329) with videos related to
Page
of 33
Sort By:
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
May 31, 2001
High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase
P M Gillett, H R Gillett, D M Israel, et al.
Cancer Research
|
November 1, 1989
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA
A Bodley, L F Liu, M Israel, et al.
The New Zealand Medical Journal
|
May 9, 1990
The use of alternative therapies by Auckland general practitioners
R J Marshall, R Gee, M Israel, et al.
Radiology
|
March 12, 2009
Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging
Bachir Taouli, Ravi K Thakur, Lorenzo Mannelli, et al.
Radiology
|
June 25, 2004
Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging
Elizabeth M Hecht, Gary M Israel, Glenn A Krinsky, et al.
Cancer Treatment Reports
|
September 1, 1983
Doxorubicin in pregnancy: possible transplacental passage
G I Karp, P von Oeyen, F Valone, et al.
Journal of Agricultural and Food Chemistry
|
July 7, 2005
Mycoflora and occurrence of alternariol and alternariol monomethyl ether in Brazilian sunflower from sowing to harvest
Claudia R Pozzi, Raquel Braghini, Juliana R P Arcaro, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II
R Silber, L F Liu, M Israel, et al.
The Laryngoscope
|
December 29, 2000
Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck
M K Wani, Y Koseki, R H Yarber, et al.
Cancer Treatment Reports
|
May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusion
K C Anderson, M B Garnick, M W Meshad, et al.
Page
of 33
Search research articles
Search
Showing results (301-310 of 329) with videos related to
Sort By:
Page
of 33
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
May 31, 2001
High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase
P M Gillett, H R Gillett, D M Israel, et al.
Cancer Research
|
November 1, 1989
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA
A Bodley, L F Liu, M Israel, et al.
The New Zealand Medical Journal
|
May 9, 1990
The use of alternative therapies by Auckland general practitioners
R J Marshall, R Gee, M Israel, et al.
Radiology
|
March 12, 2009
Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging
Bachir Taouli, Ravi K Thakur, Lorenzo Mannelli, et al.
Radiology
|
June 25, 2004
Renal masses: quantitative analysis of enhancement with signal intensity measurements versus qualitative analysis of enhancement with image subtraction for diagnosing malignancy at MR imaging
Elizabeth M Hecht, Gary M Israel, Glenn A Krinsky, et al.
Cancer Treatment Reports
|
September 1, 1983
Doxorubicin in pregnancy: possible transplacental passage
G I Karp, P von Oeyen, F Valone, et al.
Journal of Agricultural and Food Chemistry
|
July 7, 2005
Mycoflora and occurrence of alternariol and alternariol monomethyl ether in Brazilian sunflower from sowing to harvest
Claudia R Pozzi, Raquel Braghini, Juliana R P Arcaro, et al.
NCI Monographs : a Publication of the National Cancer Institute
|
January 1, 1987
Metabolic activation of N-acylanthracyclines precedes their interaction with DNA topoisomerase II
R Silber, L F Liu, M Israel, et al.
The Laryngoscope
|
December 29, 2000
Rationale for intralesional valrubicin in chemoradiation of squamous cell carcinoma of the head and neck
M K Wani, Y Koseki, R H Yarber, et al.
Cancer Treatment Reports
|
May 1, 1983
Phase I trial of mitoxantrone by 24-hour continuous infusion
K C Anderson, M B Garnick, M W Meshad, et al.
Page
of 33